Inventors list |
Assignees list |
Classification tree browser |
Top 100 Inventors |
Top 100 Assignees |
Chiara
Chiara Allegrini, Lucca IT
| Patent application number | Description | Published |
|---|---|---|
| 20090018517 | COMPOSITE ABSORBENT MATERIAL WITH WATER-SOLUBLE BONDING AGENTS, PRODUCTS MADE OF SAID MATERIAL NAD METHOD FOR ITS MANUFACTURE - A method is described for the manufacture of a composite absorbent material comprising the following stages: superabsorbent particles (P) are distributed on at least one first textile web (V | 01-15-2009 |
| 20090035515 | METHOD FOR PRODUCING A WEBLIKE PRODUCT FOR THE PRODUCTION OF ABSORBENT ITEMS AND SIMILAR, PRODUCT SO OBTAINED AND ABSORBENT ARTICLE INCLUDING SAID PRODUCT - A method for the production of a weblike material including a flocked substrate (F) is described, in which: on at least a first side of the substrate (F) is applied an adhesive (R); on said first face are distributed flock fibers ( | 02-05-2009 |
| 20090221982 | ELASTIC MATERIAL COATED IN FIBERS, A DIAPER COMPRISING SAID ELASTIC MATERIAL AND A METHOD FOR THE PRODUCTION THEREOF - The composite material comprises an elastic film (F), made of polymer material, and a coating made of flocked fibers ( | 09-03-2009 |
Chiara Azzari, Firenze IT
| Patent application number | Description | Published |
|---|---|---|
| 20100167272 | Method for Detecting and Analyzing Pathogens in a Sample - The present invention relates to a method and kits thereof for detecting the presence and/or the specific serogroup of a prokaryote selected from the group consisting of & | 07-01-2010 |
Chiara Bechini, Pisa IT
| Patent application number | Description | Published |
|---|---|---|
| 20090292129 | PROCESS FOR RESOLVING RACEMIC MIXTURES AND A DIASTEREOISOMERIC COMPLEX OF A RESOLVING AGENT AND AN ENANTIOMER OF INTEREST - A process for resolving a compound in racemic form comprising the following steps is described: a) reacting a compound in racemic form with a resolving agent, b) forming a diastereoisomeric complex of the resolving agent and an enantiomer of interest, c) separating the enantiomer of interest from the obtained diastereoisomer, wherein such a process is characterized in that said resolving agent is a compound of Formula (I). A diastereoisomeric complex between the resolving agent of Formula (I) and the enantiomer of interest is also described. The process according to the invention allows acid and basic racemic mixtures to be separated. | 11-26-2009 |
Chiara Bovolenta, Milan IT
| Patent application number | Description | Published |
|---|---|---|
| 20080286248 | Hiv Vif Mutants - A polynucleotide comprising a nucleotide sequence encoding Vif, wherein each of the amino acids corresponding to positions 127, 128, 130, 131, 132 and 142 of the amino acid sequence in FIG. | 11-20-2008 |
Chiara Braconi, Columbus, OH US
| Patent application number | Description | Published |
|---|---|---|
| 20110250608 | USE OF ULTRACONSERVED RNA IN DETECTION AND TREATMENT OF CANCER - A method of analyzing a biological specimen to detect cancer in a subject, involving determining an ultraconserved RNA in the specimen and comparing the expression level to a control. The ultraconseved RNA may be uc.338 and may be used to detect hepatocellular cancer. Transcript RNA encoding ultraconserved RNA may also be used to detect cancer. Anti-cancer compositions and tumor-suppressing agents for treating cancer are also provided. | 10-13-2011 |
Chiara Busto, Trecate-Novara IT
| Patent application number | Description | Published |
|---|---|---|
| 20100184593 | METHOD TO ACTIVATE A CATALYST FOR A CONTINUOUS PROCESS FOR THE PREPARATION OF PHENOL FROM BENZENE IN A FIXED BED REACTOR - A process to activate a titanium silicalite catalyst for the oxidation of benzene to phenol is provided. The catalyst is activated in the reactor for the oxidation by feeding to a reactor containing the titanium silicalite catalyst, during a time of from 2 to 6 hours, at a temperature ranging from 20 to 120° C., an aqueous solution of ammonium acid fluoride in a concentration ranging from 0.1% to 1% by weight; and hydrogen peroxide in a concentration ranging from 3% to 10% by weight; feeding water to the reactor at the end of the reaction; and drying or calcining the catalyst contained in the reactor to obtain the activated catalyst. The catalyst is represented by the formula: | 07-22-2010 |
Chiara Cappellini, Erba (como) IT
| Patent application number | Description | Published |
|---|---|---|
| 20090114823 | RADIATION MEASURING DEVICE - A radiation measuring device to determine the intensity and/or the dose of the ionizing radiation during a radiological examination of a patient is provided, with the radiation measuring device ( | 05-07-2009 |
Chiara Casolari, Modena IT
| Patent application number | Description | Published |
|---|---|---|
| 20100048692 | Naphthofuranone Derivatives as Specific Inhibitors of Thymidylate Synthases - Synthetic compounds of 1,2-naphthalein moelcules (I) having specific inhibitory properties of the enzymatic activity of thymidylate synthases of bacterial species, their preparation, their pharmaceutical composition and use in the treatment and prophylaxis of infectious pathologies are disclosed. | 02-25-2010 |
Chiara Dalla Man, Venezia IT
| Patent application number | Description | Published |
|---|---|---|
| 20100262117 | PREDICTIVE CONTROL BASED SYSTEM AND METHOD FOR CONTROL OF INSULIN DELIVERY IN DIABETES USING GLUCOSE SENSING - A system and method for providing optimal insulin injections to a subject, using a controller, a continuous glucose monitor, and an insulin delivery unit is disclosed. The controller possesses a discrete-time, linear model predictive control law, means for sending information to the insulin delivery unit, and means for receiving information from the CGM. The control law implemented is derived from a discrete-time model of glucose insulin dynamics and an aggressiveness parameter. The result is that using only glucose measurements obtained from sensor readings and, prior values of external insulin infusion and meal and exercise announcement the optimal insulin injection necessary to safely regulate blood glucose can be calculated. | 10-14-2010 |
| 20120130698 | System, Method and Computer Simulation Environment For In Silico Trials in Pre-Diabetes and Type 2 Diabetes - An electronic system is provided that simulates a glucose-insulin metabolic system of a T2DM or prediabetic subject, wherein the system includes a subsystem that models dynamic glucose concentration in a T2DM or prediabetic subject, including an electronic module that models endogenous glucose production (EGP(t)), or meal glucose rate of appearance (Ra(t>>, or glucose utilization (U(t)), or renal excretion of glucose (B(t)), a subsystem that models dynamic insulin concentration in said T2DM or prediabetic subject, including an electronic module that models insulin secretion (S(t)), an electronic database containing a population of virtual T2DM or prediabetic subjects, each virtual subject having a plurality of metabolic parameters, and a processing module that calculates an effect of variation of at least one metabolic parameter value on the glucose insulin metabolic system of a virtual subject by inputting the plurality of metabolic parameter values. | 05-24-2012 |
Chiara Dalla Man, Venice IT
| Patent application number | Description | Published |
|---|---|---|
| 20100179768 | Method, System and Computer Simulation Environment for Testing of Monitoring and Control Strategies in Diabetes - A simulation environment for in silico testing of monitoring methods, open-loop and closed-loop treatment strategies in type 1 diabetes. Some exemplary principal components of the simulation environment comprise, but not limited thereto, the following: 1) a “population” of in silico “subjects” with type 1 diabetes in three age groups; 2) a simulator of CGM sensor errors; 3) a simulator of insulin pumps and discrete insulin delivery; 4) an interface allowing the input of user-specified treatment scenarios; and 5) a set of standardized outcome measures and graphs evaluating the quality of the tested treatment strategies. These components can be used separately or in combination for the preclinical evaluation of open-loop or closed-loop control treatments of diabetes. | 07-15-2010 |
Chiara Dall'Ara, Masera' IT
| Patent application number | Description | Published |
|---|---|---|
| 20090030343 | Process for the production of interchangeable vacuum test tube holders for taking blood samples and product obtained therefrom - A process for the production of a tubular holder for vacuum test tubes and the holder obtained therefrom. The process includes the steps of inserting a straight needle into the holder and the subsequent bending of the needle, so that the outer end of the needle is first connected to the edge of a slanted support wall extending from the casing and has a terminal portion aligned with a side wall of the casing, thus facilitating the insertion of the needle into the limb of a patient. The new disposable holder is particularly useful for blood sampling because it provides for the alignment of the needle with respect to the patient's vein. | 01-29-2009 |
Chiara Daraio, Pasadena, CA US
| Patent application number | Description | Published |
|---|---|---|
| 20090199643 | ACTUATION SYSTEM - A method and system for creating highly nonlinear solitary waves for use in performing nondestructive evaluation of structures and materials. The method and system use an apparatus having a spring loaded adjustable striker, a chain of granular particles, and a reloading device that allows for repeated activation of the adjustable striker. | 08-13-2009 |
| 20090204344 | METHOD AND APPARATUS FOR NONDESTRUCTIVE EVALUATION AND MONITORING OF MATERIALS AND STRUCTURES - A method and apparatus for nondestructive evaluation (NDE) of structures and materials using a highly nonlinear medium for the generation and detection of one or multiple highly nonlinear pulses (or highly nonlinear waves) impinging on a material or structure. The apparatus includes pulse exciters that induce the propagation of highly nonlinear, weakly nonlinear or linear stress waves in the material, system, or structure to be inspected and/or detectors for the observation and the detection of the output waves from the material/structure being tested. The NDE method includes the use of the tunable highly nonlinear apparatus as impulse exciter alone, or in combination with an accelerometer or a nonlinear sensor to detect the outgoing pulse. | 08-13-2009 |
| 20090229910 | METHOD AND SYSTEM FOR FORMATION OF HIGHLY NONLINEAR PULSES - A method and system supporting the formation and propagation of tunable highly nonlinear pulses using granular chains composed of non-spherical granular systems. Such a method and system may be used to support the creation of tunable acoustic band gaps in granular crystals formed of particles with different geometries (spherical or not) in which the tunability is achieved by varying the static precompression, type of excitation and/or pulse amplitude in the system. | 09-17-2009 |
| 20110209940 | SYSTEMS AND METHODS FOR CONTROLLING HIGHLY NONLINEAR ACOUSTIC WAVES OR PULSES - Systems and methods for creating sound bullets are described. Such sound bullets are created by controlling and/or redirecting highly nonlinear acoustic waves or pulses propagating through an array of actuators. The controlling and/or redirecting of the acoustic waves or pulses is achieved though methods such as applying pre-compressive forces to the array of actuators or by selection of size, shape and/or material of the actuators. | 09-01-2011 |
Chiara De Gregorio, Cori(latina) IT
| Patent application number | Description | Published |
|---|---|---|
| 20100113403 | COMPOSITIONS CONTAINING COMPOUNDS HAVING STEROID STRUCTURE AND THEIR USE FOR INDUCING THE PROLIFERATION AND DIFFERENTIATION OF STEM CELLS OF THE ORGANISM - Use of a mixture of phytosterols, selected from the group comprising: brassicasterol (Delta 5-C22 unsaturated); campesterol; campestanol; stigmasterol (Delta 5-C22 unsaturated); Delta 5-C23-stigmastadienol; clerosterol (Delta 8-C25 unsaturated); Beta-sitosterol; sitostanol; Delta 5-venasterol (Delta 5-C24 unsaturated); Delta 5-C24-stigmastadienol (Delta 5-C24 diene unsaturated); Delta 7-stigmastenol; 24-methylene-cycloartenol; gramisterol; 24-methylcholest-7-enol; isofucosterol; Delta 7-avenasterol (Delta 7-C24 unsaturated); Delta 5-avenastenol, for the manufacture of a medicament to induce into the adult organism proliferation and differentiation of the stem cells which are present in the organism. | 05-06-2010 |
Chiara Del Sarto, Torino IT
| Patent application number | Description | Published |
|---|---|---|
| 20120090762 | ADHESIVE ELEMENT FOR ADHESION TESTS AND CORRESPONDING TESTING PROCESS - An adhesive element for adhesion tests, comprising a bi-adhesive layer including a first adhesive surface, designed to co-operate in a relation of adhesion with a surface undergoing testing, and a second adhesive surface. The adhesive element further comprises a support layer having a comparative adhesion surface designed to co-operate in a relation of adhesion with the second adhesive surface. The bi-adhesive layer has a fragmented structure. | 04-19-2012 |
Chiara De Martini, Milano IT
| Patent application number | Description | Published |
|---|---|---|
| 20110025383 | METHOD OF ENHANCING POWER SAVING IN AN INTEGRATED ELECTRONIC SYSTEM WITH DISTINCTLY POWERED ISLANDS OF FUNCTIONAL CIRCUITRIES AND RELATED DEVICE ARCHITECTURE - A method for power saving in an integrated circuit device may include defining an off-switchable analog circuit island including an internal clock generating circuit, and at power-on of the integrated circuit device, supplying to clocked digital circuits of the integrated circuit device an auxiliary clock from the external controller. The auxiliary clock has a frequency determined by the external controller and being lower than the root clock signal. The method includes supplying external reset commands to the integrated circuit device until an active functioning condition of the integrated circuit device is asserted, and interrupting the supply of the auxiliary clock and enabling supply of the root clock signal to the clocked digital circuits when the active functioning condition of the integrated circuit device is asserted. | 02-03-2011 |
Chiara Dionigi, Bologna IT
| Patent application number | Description | Published |
|---|---|---|
| 20090017284 | DEVICE COMPRISING A CHARGE TRANSFER CHANNEL AND METHOD FOR MANUFACTURING THE SAME - A device comprising a charge transfer channel, wherein the charge transfer channel comprises a composite material which comprises particles of a dielectric material with interstice voids between them which are partially or totally infilled by a semiconductor or conductor material. | 01-15-2009 |
Chiara Falciani, Siena IT
| Patent application number | Description | Published |
|---|---|---|
| 20110190198 | PEPTIDE SEQUNCES, THEIR BRANCHED FORM AND USE THEREOF FOR ANTIMICROBIAL APPLICATIONS - The present invention relates to an antibacterial peptide having from the amino to the carboxylic terminal an amino acid sequences selected from the group of: KKIRVRLSA, SEQ ID NO. 1, RRIRVRLSA, SEQ ID NO. 2, KRIRVRLSA, SEQ ID NO. 3, RKIRVRLSA, SEQ ID NO. 4 or a derivative thereof and uses thereof. | 08-04-2011 |
| 20110319339 | NEUROTENSIN-DERIVED BRANCHED PEPTIDES AND USES THEREOF - The present invention relates to a multimeric molecule having the general formula A or B: | 12-29-2011 |
Chiara Fanali, Roma IT
| Patent application number | Description | Published |
|---|---|---|
| 20110079076 | MOLECULAR MARKERS FOR AUTISM - The invention relates to the determination of phosphorylation levels of some specific salivary peptides (statherin, histatin 1, acidic proline-rich proteins, both in whole form (PRP-1 type) and in truncated form (PRP-3 type) as a non-invasive diagnostic marker with a >40% sensitivity for defining autism spectrum disorders (ASDs) patients, methods for performing said determination, a kit for the non-invasive diagnosis of at least 40% of autism cases, containing means for such a determination, and the use of such a determination for therapeutical research on autism. | 04-07-2011 |
Chiara Ferrandi, Moncalieri IT
| Patent application number | Description | Published |
|---|---|---|
| 20090176762 | JNK Inhibitors for Treatment of Skin Diseases - This invention relates to the use of a JNK inhibitor for treating and/or preventing skin diseases selected from psoriasis and dermatitis. | 07-09-2009 |
Chiara Garbolino, At Vlaardingen NL
| Patent application number | Description | Published |
|---|---|---|
| 20090017163 | Composition comprising bacteria and lecithin - The present invention relates to a composition comprising live food grade bacterium and lecithin wherein the water activity of the composition is at least 0.5 and the amount of fat is between 10 and 80 wt %. It was surprisingly found that lecithin enhances the viability of bacteria in compositions. | 01-15-2009 |
Chiara Garbolino, Vlaardingen NL
| Patent application number | Description | Published |
|---|---|---|
| 20080268130 | Edible fat continuous spreads - The invention relates to an edible fat continuous spread comprising from 5 to 85 wt % fat and from 0.1 to 20 wt % plant sterol wherein the plant sterol is present in the form of elongated crystals. The invention further relates to a process for the preparation of an edible fat continuous spread comprising plant sterol, said process comprising the mixing of a first mixture comprising triglyceride oil and plant sterol present in the form of elongated crystals with a second mixture comprising one selected from the group consisting of fat phase, water phase and mixtures thereof, to provide a third mixture. | 10-30-2008 |
| 20090041898 | Food product comprising bacteria and sorbitan fatty acid - Food product comprising live food grade bacterium and sorbitan fatty acid ester. It was surprisingly found that sorbitan fatty acid ester enhances the viability of bacteria in food products. | 02-12-2009 |
| 20090136645 | Granules Comprising Sterol - Granule comprising lipid powder particles having a microporous structure and comprising sterol. | 05-28-2009 |
Chiara Lorenzetto, Torino IT
| Patent application number | Description | Published |
|---|---|---|
| 20110311451 | SYNTHESIS OF POLYMER CONJUGATES OF INDOLOCARBAZOLE COMPOUNDS - The present invention relates to a process for the preparation of polymer conjugates of iπdolocarbazole compounds, in particular of polymer conjugates of K-252a and derivatives thereof, by a synthetic route which results in a highly pure product, with a high product yield. In a further aspect the present invention relates to novel polymer conjugates of K-252a and derivatives thereof, wherein the chemical group linking the polymer unity to the K-252a or to the K-252a derivative compound is characterised by a 5-member oxazolidindionic cyclic structure. These novel polymer conjugates are obtained through the novel synthetic route with high purity and high yields, | 12-22-2011 |
Chiara Lorenzetto, Villafranca Piemonte IT
| Patent application number | Description | Published |
|---|---|---|
| 20090324677 | POLYMER CONJUGATES OF BOX-A OF HMGB1 AND BOX-A VARIANTS OF HMGB1 - The present invention relates to novel polymer conjugates of polypeptide variants of the HMGB1 high affinity binding domain Box-A (HMGB1 Box-A) or of a biologically active fragment of HMGB1 Box-A. Further, the invention relates to novel polymer conjugates of polypeptide variants of the HMGB1 high affinity binding domain Box-A (HMGB1 Box-A). Moreover, the present invention concerns the use of said polymer conjugates of polypeptide molecules of HMGB1 Box-A to diagnose, prevent, alleviate and/or treat pathologies associated with extracellular HMGB1 and/or associated with an increased expression of RAGE. | 12-31-2009 |
| 20110052493 | USE OF POLYPEPTIDES OBTAINED THROUGH SYSTEMATIC MUTATIONS OF SINGLE AMINO ACIDS OF HUMAN AND NON-HUMAN BOX-A OF HMGB1 TO PREVENT AND/OR ANTAGONIZE PATHOLOGIES INDUCED BY HMGB1 - The present invention relates to polypeptide variants of the HMGB-1 high affinity binding domain Box-A (HMGB1 Box-A) or to a biologically active fragment of HMGB1 Box-A, which are obtained through systematic mutations of single amino acids of the wild-type HMGB1 Box-A protein and which show an increased resistance to proteases and which are therefore characterized by more favourable pharmacokinetic and pharmacodynamic profiles. Moreover, the present invention concerns the use of said polypeptide molecules of HMGB1 Box-A to diagnose, prevent, alleviate and/or treat pathologies associated with extracellular HMGB1 and associated with RAGE. | 03-03-2011 |
Chiara Malvolti, Parma IT
| Patent application number | Description | Published |
|---|---|---|
| 20100098642 | OPTIMISED FORMULATION OF TOBRAMYCIN FOR AEROSOLIZATION - The invention provides a tobramycin formulation for delivery by aerosolization in the form of additive-free, isotonic solution whose pH has been optimised to ensure adequate shelf-life at room temperature. Said formulation can be advantageously used for the treatment and prophylaxis of acute and chronic endobronchial infections, in particular those caused by the bacterium | 04-22-2010 |
| 20110212912 | OPTIMISED FORMULATION OF TOBRAMYCIN FOR AEROSOLIZATION - The invention provides a tobramycin formulation for delivery by aerosolization in the form of additive-free, isotonic solution whose pH has been optimised to ensure adequate shelf-life at room temperature. Said formulation can be advantageously used for the treatment and prophylaxis of acute and chronic endobronchial infections, in particular those caused by the bacterium | 09-01-2011 |
Chiara Martinelli-Cattaneo, Sergy FR
| Patent application number | Description | Published |
|---|---|---|
| 20080291888 | Method and Device for Carrying Out Flexible Demodulation in an Ofdm-Cdma System - This method for carrying out the flexible demodulation of data modulated following an amplitude modulation in quadrature is used in a communications system employing a code division multiple access technique (CDMA) and an optical frequency division multiplexing (OFDM) using non-binary spread codes. The invention includes steps for determining a simplified expression specific to the logarithm of the likelihood ratio. | 11-27-2008 |
| 20090296784 | METHOD AND DEVICE FOR NOTCHING THE TRANSMISSION BAND OF AN ANALOG SIGNAL, IN PARTICULAR FOR A DETECT AND AVOID (DAA) OPERATION MODE OF AN MB-OFDM SYSTEM - A transmission band of an analog signal including successive symbols to be transmitted is notched, where each symbol includes sub-carriers to be modulated. In particular, in each symbol the sub-carriers corresponding to a part of the transmission band to be notched are suppressed. In addition, in each symbol a chosen part of the remaining sub-carriers to be modulated is also suppressed. | 12-03-2009 |
Chiara Mingardi, Vicenza IT
| Patent application number | Description | Published |
|---|---|---|
| 20110138032 | METHOD FOR MANAGING A NETWORK AND A NETWORK - For providing a significant reduction of resource consumption and network traffic within a network a method for managing a network is claimed, the network including: a plurality of network elements, each of which being able to run at least one network management function and to store management information being necessary for running the at least one management function, the method being characterized by randomly activating and deactivating the at least one management function on one or more of the network elements by a randomization process. Further, an according network is claimed, preferably for carrying out the above mentioned method. | 06-09-2011 |
Chiara Parlati, Parma IT
| Patent application number | Description | Published |
|---|---|---|
| 20110097409 | PARTICLES COMPRISING A SALT OF 8-HYDROXY-2-[[(1R)-2-(4-METHOXYPHENYL)-1-METHYLETHYL]AMINO]ETHYL]-2(1H)-Q- UINOLINONE HAVING IMPROVED ADHESION PROPERTIES FOR POWDER FORMULATIONS FOR INHALATION - Powder particles comprising a pharmaceutically acceptable salt of 8-hydroxy-5-[(1R)-1-hydroxy-2-[[(1R)-2-(4-methoxyphenyl)-1-methylethyl]amino]ethyl]-2(1H)-quinolinone (carmoterol) having a specific properties exhibit improved adhesion properties for dry powder formulations for inhalation. Such particles are useful for formulations in the form of powders for inhalation and the treatment of certain conditions and diseases. | 04-28-2011 |
Chiara Piglione, San Jose, CA US
| Patent application number | Description | Published |
|---|---|---|
| 20090010162 | Flexible and hierarchical dynamic buffer allocation - In one embodiment, a method comprises the following steps: receiving a first set of inputs comprising a first plurality of entities and a first traffic behavior; determining a first region of a buffer corresponding to the first traffic behavior; assigning the first plurality of entities to the first region; determining hierarchical relationships between at least some of the first plurality of entities; determining a first shared buffer space of the first region; and assigning at least one threshold for each of the first plurality of entities. The threshold may comprise a maximum amount of the first shared buffer space that may be allocated to an entity. The method may also involve configuring a logic device to allocate the first shared buffer space dynamically according to the hierarchical relationships and the thresholds. | 01-08-2009 |
| 20100296398 | Apparatus and Methods for Hybrid Fair Bandwidth Allocation and Drop Precedence - In one embodiment, apparatus and methods for apparatus and methods for fair bandwidth allocation are disclosed. In one embodiment, a method includes (i) determining a drop probability for each of a plurality of classes of packets being dropped or admitted to a queue, wherein each drop probability is based on a weighted fair bandwidth allocation process that is performed with respect to the plurality of classes and a plurality of packet arrival rates and predefined weights for such classes; and (ii) dropping a particular packet or admitting such particular packet to the queue based on the drop probability for such particular packet's class, wherein such dropping or admitting operation is further based on one or more drop precedence factors that are also determined periodically for each class if such one or more drop precedence factors are selected for such each class. In other embodiments, the invention pertains to an apparatus having one or more processors and one or more memory, wherein at least one of the processors and memory are adapted for performing the above described method operations. | 11-25-2010 |
Chiara Regale, Santa Clara, CA US
| Patent application number | Description | Published |
|---|---|---|
| 20090010265 | Flexible mapping of virtual local area networks to Ethernet virtual circuits - A method includes configuring multiple Ethernet Virtual Circuits (EVCs) for communicating with respective service gateways that provide respective communication services. A data packet, which belongs to a Virtual Local Area Network (VLAN) and is associated with a communication service from among the communication services, is accepted. The data packet is mapped to an EVC from among the multiple EVCs responsively to the VLAN to which the data packet belongs and to the communication service with which the data packet is associated. The data packet is sent over the EVC to the service gateway, in order to provide the communication service. | 01-08-2009 |
Chiara Rodighiero, Essex GB
| Patent application number | Description | Published |
|---|---|---|
| 20100111768 | SYSTEMS AND DEVICES FOR SEQUENCE BY SYNTHESIS ANALYSIS - The present invention comprises systems and devices for sequencing of nucleic acid, such as short DNA sequences from clonally amplified single-molecule arrays. | 05-06-2010 |
Chiara Savardi, Sesto San Giovanni (milano) IT
| Patent application number | Description | Published |
|---|---|---|
| 20080213970 | PROCESS FOR THE FORMATION OF DIELECTRIC ISOLATION STRUCTURES IN SEMICONDUCTOR DEVICES - A process for forming a dielectric isolation structure on a silicon substrate includes forming at least one trench in the substrate, performing a high-temperature treatment in an oxidizing environment to form a first liner layer of silicon dioxide on the walls and the bottom of the trench, and performing a silicon dioxide deposition treatment to form a second liner layer on the first liner layer. A silicon nitride deposition treatment is also performed to form a third liner layer on the second liner layer. The trench is filled with isolating material. | 09-04-2008 |
Chiara Schiraldi, Napoli IT
| Patent application number | Description | Published |
|---|---|---|
| 20120135470 | BIOTECHNOLOGICAL PRODUCTION OF CHONDROITIN - An innovative method is described for the production of chondroitin at high concentration, by fermentation of genetically mutated bacteria. | 05-31-2012 |
Chiara Schivalocchi, Roe' Volciano IT
| Patent application number | Description | Published |
|---|---|---|
| 20090071326 | Piston For Cold Chamber Die-Casting Machine - The object of the present invention is a piston for cold chamber die-casting machines comprising a body and at least one sealing band mounted around said body, wherein said body and said band are provided with coupling means suitable for concurrently obtaining both an angular locking and an axial locking of the band to the piston body. | 03-19-2009 |
Chiara Vitale Brovarone, Torino IT
| Patent application number | Description | Published |
|---|---|---|
| 20100179662 | MONOBLOCK CERAMIC PROSTHESIS DEVICES - Single-piece prosthesis elements chosen from among acetabular cup for hip prosthesis, tibial component and femoral component for knee prosthesis, comprising a body ( | 07-15-2010 |
Chiara Vladiskovic, Milano IT
| Patent application number | Description | Published |
|---|---|---|
| 20090062534 | LINEZOLID CRYSTALLINE HYDRATE FORM AND LINEZOLID SALTS - Linezolid salts, useful as such and as intermediates in a process for the preparation of novel and known crystalline linezolid forms, in particular known as Form III. | 03-05-2009 |
| 20090203915 | Process for the preparation of solifenacin - A process for the preparation of (1S,3′R)-quiniclidin-3′-yl-1-phenyl-3,4-dihydro-1H-isoquinolin-2-carboxylate, namely solifenacin, comprising the reaction of a compound of formula (IV) with a compound of formula (V), as herein defined, | 08-13-2009 |
| 20100204479 | CRYSTALLINE FORMS OF DEXLANSOPRAZOLE - The present invention relates to novel crystalline forms of Dexlansoprazole and a process for the preparation of amorphous Dexlansoprazole. | 08-12-2010 |
| 20110028728 | PROCESS FOR THE PREPARATION OF CRYSTALLINE DEXLANSOPRAZOLE - Process for the preparation of crystalline anhydrous (R)-2-[[[3-methyl-4-(2,2,2-trifluoroetoxy)-2-piridyl]methyl]sulphinyl]benzimidazole (dexlansoprazole). | 02-03-2011 |
| 20110034523 | CRYSTALLINE FORMS OF RUFINAMIDE - Disclosed is a crystalline form of rufinamide selected from: | 02-10-2011 |
Chiara Zambetti, Baden CH
| Patent application number | Description | Published |
|---|---|---|
| 20110293402 | GAS TURBINE - A gas turbine including an inner casing and a rotor having rotatable blades with a shroud and a fin, and a cooling arrangement arranged in a cavity in the casing and about the rotatable blade. The blade shroud includes a protrusion extending away from the blade leading edge into the cavity and openings in the cavity wall for a cooling fluid. The protrusion is defined by angles in relation to the flow channel wall. The protrusion affects a vortex flow of cooling fluid entering through the openings and a vortex flow of hot gas entering from the flow channel into the cavity. The double-vortex formation reduces a mixing of the cooling flow with the hot gas flow and increases the efficiency of the cooling arrangement of the blade shroud and cavity walls. | 12-01-2011 |
| 20120070309 | BLADE FOR A GAS TURBINE - A blade, for a gas turbine, includes a blade airfoil, having a shroud segment arranged on its upper end. The shroud segment together with shroud segments of other blades of a blade row forming an annular shroud which delimits hot gas passage of the gas turbine, and said shroud segment, on sides on which it adjoins adjacent shroud segments of the annular shroud, is provided with upwardly projecting side rails which extend along a side edge, to improve sealing to the hot gas passage. The side rails include rail-parallel or essentially rail-parallel, upwardly open slots through which cooling air, which is introduced via the shroud segment from an interior of the blade airfoil, discharges into the space above the shroud segment. | 03-22-2012 |
Chiara Zingaretti, Siena IT
| Patent application number | Description | Published |
|---|---|---|
| 20110110967 | GAS57 MUTANT ANTIGENS AND GAS57 ANTIBODIES - The invention provides mutants of GAS57 which are unable to cleave IL-8 and similar substrates but which still maintain the ability to induce protection against | 05-12-2011 |